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This study assessed progress towards tuberculosis
(TB) elimination in the Netherlands by using DNA finger-
printing. Mycobacterium tuberculosis strains were defined
as new if the IS6110 restriction fragment length polymor-
phism pattern had not been observed in any other patient
during the previous 2 years. Other cases were defined as
clustered and attributed to recent transmission. In the peri-
od 1995–2002, the incidence of TB with new strains was
stable among non-Dutch residents and declined among the
Dutch. However, the decline among the Dutch was restrict-
ed to those >65 years of age. Moreover, the average num-
ber of secondary cases per new strain did not change
significantly over time. We conclude that the decline of TB
in the Netherlands over the past decade was mainly the
result of a cohort effect: older birth cohorts with high infec-
tion prevalence were replaced by those with lower infection
prevalence. Under current epidemiologic conditions and
control efforts, TB may not be eliminated. 
R
eported rates of tuberculosis (TB) in the Netherlands
in 2003 were 3.5 per 100,000 among Dutch residents
and 125 per 100,000 among the non-Dutch. The non-
Dutch are formally defined as those without a Dutch pass-
port, but in practice they include mostly foreign-born
persons. During the past 10 years, TB reports in the
Netherlands declined among the Dutch (from 693 in 1993
to 531 in 2002) and remained approximately stable among
the non-Dutch (at an average of 892 per year). To what
extent these patterns were attributable to changes in TB
transmission and to what extent to changes in the introduc-
tion of new strains from abroad or from reactivation of
latent infection are unclear. 
According to mathematical models, eliminating TB as
a public health problem, defined as a prevalence of
Mycobacterium tuberculosis infection of <1%, has been
predicted to occur among the Dutch by 2030 if no further
changes in transmission occur (1,2). However, if elimina-
tion is defined as an incidence of smear-positive disease of
<1 case per million population per year (1), TB is not
expected to be eliminated by that date because of transmis-
sion from foreign-source cases (2). The proportion of all
Dutch TB cases in the period 1993–1998 attributable to
recent transmission from a non-Dutch source case has been
estimated at 12% to 20% with DNA-fingerprinting data
(3). With time, an increasing proportion of TB cases
among the Dutch were expected to be attributable to recent
transmission from non-Dutch source cases (2). However,
direct observations with fingerprinting results have not yet
been used to evaluate these model predictions.
Immigration patterns in the Netherlands have varied in
the past decade: large numbers of persons from countries
with high TB endemicity have sought asylum in the early
1990s. In recent years, these numbers became smaller after
stricter immigration laws were passed. Shifts in countries
of origin of immigrants have also occurred, and some of
these countries had much higher TB rates than others.
Therefore, the introduction of new strains from abroad
may be expected to have varied over time. Control meas-
ures, in contrast, have shown little change over the study
period. TB screening is obligatory at entry and is offered
every 6 months for 2 years on a voluntary basis. No rou-
tine screening for and treatment of latent infection exist for
immigrants.
This study attempted to determine, by DNA-finger-
printing of M. tuberculosis isolates, to what extent TB
trends from 1995 to 2002 were determined by changes in
the introduction of new strains and by changes in ongoing
transmission. We also describe the trend of TB transmis-
sion from non-Dutch source patients to the Dutch popula-
tion. The combined evidence is used to assess the
prospects for eliminating TB in the Netherlands.
Methods
Patient and treatment data since 1993 were available in
the Netherlands Tuberculosis Register, an anonymous case
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Reporting to the register is voluntary, but cross-matching
with mandatory reports to the ministry of health on all
patients who have started TB treatment suggests >99%
completeness. The register includes data on demographic
characteristics, clinical features, risk groups, treatment
given, and treatment outcome. From January 1993 to
December 2002, a total of 15,331 TB patients were regis-
tered, including those without bacteriologic confirmation. 
Over the same period, 10,356 first M. tuberculosis iso-
lates of TB patients were subjected to standard IS6110
restriction fragment length polymorphism (RFLP) analysis
(4). Subtyping with the polymorphic GC-rich sequence
probe was carried out for strains with <5 IS6110 copies.
IS6110 RFLP patterns were analyzed by using the
Bionumerics software, version 3.5 for Windows (Applied
Maths, Sint-Martens-Latem, Belgium). 
Information from the 2 databases was combined; sex,
date of birth, postal area code, and year of diagnosis were
used as identifiers. Aperfect match was obtained for 7,529
(73%) isolates and a near-perfect match for 981 (9%). Both
groups were included, yielding a total study size of 8,510
(82%) culture-positive patients. Mismatches may be due to
administrative errors in a database, unreliable date of birth
(e.g., for some immigrant groups), or postal area code
(e.g., homeless), and the exclusion of persons with identi-
cal identifiers.
TB can occur soon after primary infection or reinfec-
tion (recent transmission) or as the result of endogenous
reactivation of latent infection (5). The cut-off point for
separating recent from remote transmission is arbitrary:
some researchers used 5 years (5–7), others 2 years (8),
and others 1 year (9). We estimated the percentage of cases
with identical RFLPpatterns occurring within a given peri-
od after each culture-positive case with Kaplan-Meier sur-
vival analysis, as suggested by Jasmer et al. (9). The
Kaplan-Meier estimate of the probability that a patient was
followed by another with an identical fingerprint was
46.2% for the total study period and 33.7% for a 2-year
period. Thus, of all cases followed by a patient with an
identical fingerprint within 10 years, 73% were followed
within 2 years. Using this information, we defined strains
as new if the RFLPpattern had not been observed in anoth-
er patient during the previous 2 years. Other strains were
attributed to ongoing transmission. During the first 2 study
years (1993–1994), judging whether strains were new was
not possible; therefore, data from these 2 years were used
to define new strains from 1995 onwards but were other-
wise excluded from the analysis. 
The observation period in which secondary cases can
be observed is longer for strains introduced earlier in the
study period than for those introduced later. To obtain an
unbiased estimate of the trend of the number of secondary
cases generated by source cases, secondary cases arising
>2 years after a new strain was introduced were excluded.
Thus, all patients were assigned to 1 of the following 3
mutually exclusive categories: case with a new strain, sec-
ondary case within 2 years of the introduction of a new
strain, and secondary case >2 years after the introduction
of a new strain. To assess the trend of transmission
between Dutch and non-Dutch persons, secondary cases
were attributed to a source case-patient, defined as the
patient from whom the new strain was first isolated (10).
Population data by year, age group, sex, and
(Dutch/non-Dutch) nationality were obtained from
Statistics Netherlands (available from http://statline.
cbs.nl/StatWeb) and used as denominators for incidence
rates. Relative risks of TB by year of diagnosis, age, sex,
and Dutch or non-Dutch nationality were determined sep-
arately for new strains and secondary cases with Poisson
regression. Risk factors for the average number of second-
ary cases per new strain were also identified with Poisson
regression (3).
Results
Of the 8,510 TB patients with known RFLP results in
the period 1993–2002, 1,580 were found in 1993 to 1994,
and 6,930 in 1995 to 2002. Of the latter, 4,594 (66%) had
new strains, 1,198 (17%) had secondary cases within 2
years of the introduction of a new strain, and 1,138 (16%)
had secondary cases >2 years after a new strain was intro-
duced. 
The incidence of TB with new strains was on average
52 per 100,000 among the non-Dutch and 1.4 per 100,000
among the Dutch. The incidence declined over the study
period among the Dutch (rate ratio per year 0.96, 95% con-
fidence interval [CI] 0.94–0.98) and was stable among the
non-Dutch (rate ratio per year 1.02, 95% CI 1.00–1.03, p =
0.06) (Figure 1). The incidence of all cases attributed to
recent transmission, regardless of the duration of the clus-
ter, was 23 per 100,000 among the non-Dutch and 0.9 per
100,000 among the Dutch. The incidence declined among
the Dutch (rate ratio per year 0.97, 95% CI 0.95–1.00, p =
0.03) but not among the non-Dutch (rate ratio per year
0.99, 95% CI 0.97–1.02) (Figure 1). 
Reduction of TB incidence with new strains among the
Dutch was restricted to those >65 years of age (Figure 2).
Incidence was stable at 0.85/100,000 in the age group <65
years (rate ratio per year 1.0, 95% CI 0.97–1.03), declined
from 3.5 to 2.2 in those 65–74 years of age (rate ratio per
year 0.91, 95% CI 0.86–0.95), and declined from 9.4 to 4.8
in those >75 years of age (rate ratio per year 0.92, 95% CI
0.87–0.95). The incidence rate in the >75-year age group
declined more rapidly than the number of cases in that age
group, since the population in that age group increased
from 847,000 in 1995 to 979,000 in 2002. 
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1995–2002, a total of 3,459 were found in the period
1995–2000 and could be followed up for 2 years. Of the
1,318 Dutch patients with new strains, 182 (14%) generat-
ed secondary cases at an average of 1.7 cases per cluster
(1.2 Dutch and 0.5 non-Dutch) (Table 1). The average
number of secondary cases generated was 0.23 per new
strain and declined steeply with the age of the source case-
patient (rate ratio per age group 0.74, 95% CI 0.70–0.78)
(Table 1). The average number of secondary cases gener-
ated did not depend on the sex of the source patient (p >
0.5). The average number of secondary case-patients per
new strain did not differ significantly over time (rate ratio
per year 0.96, 95% CI 0.89–1.02). 
Of the 2,141 non-Dutch patients with new strains, 283
(13%) generated secondary cases at an average of 1.9
cases per cluster (0.5 Dutch and 1.4 non-Dutch) (Table 2).
The average number of secondary cases generated was
0.25 overall, declined with age of the source patient (rate
ratio per age group 0.86, 95% CI 0.80–0.92), and was
lower for female than male source patients (rate ratio 0.68,
95% CI 0.57–0.81) (Table 2). The average number of sec-
ondary cases per new strain over time did not change (rate
ratio per year 0.97, 95% CI 0.93–1.02). 
In clusters starting in the period 1995–2000, an increas-
ing proportion of Dutch secondary TB cases was attributa-
ble to a non-Dutch source case as time progressed (χ2
trend
4.49, p = 0.03) (Table 3). This trend was observed not only
among those cases arising within 2 years of the start of the
cluster (Table 3) but also among all Dutch secondary cases,
regardless of cluster duration (χ2
trend 42, p < 0.001, data not
shown). The proportion of Dutch secondary cases attribut-
able to a non-Dutch source case declined steeply with age,
both among all Dutch secondary case-patients (χ2
trend 41, p
< 0.001) and among those arising within 2 years of the start
of the cluster (χ2
trend 27, p < 0.001) (Table 3). The propor-
tion of cases attributed to a non-Dutch source patient was
not associated with sex of the Dutch secondary case-
patient (Table 3).
Discussion
This study suggests that the declining TB incidence
among the Dutch in the Netherlands during the past decade
has been achieved under stable control conditions. Among
the Dutch, the incidence of TB attributable to new strains
declined, particularly among the elderly. The incidence of
TB cases due to recent transmission declined as well, a
result of fewer new strains being introduced. The average
number of secondary cases per new strain did not change
significantly. An overall reduction in incidence of clus-
tered cases among the U.S.-born population was also
observed in San Francisco (9) and New York (11) and was
attributed to improved control. In the Netherlands, we do
not attribute the decline to improved control but to a cohort
effect. Research may determine to what extent the report-
ed declines in San Francisco and New York could be
explained by a reduction in number of secondary cases per
newly introduced strain and whether a cohort effect played
a role in those settings.
In industrialized countries the annual risk for M. tuber-
culosis infection has declined steeply over the past centu-
ry (12); as a result, compared to younger persons, older
persons were exposed to much higher risks for infection in
their youth (13). Thus, the prevalence of infection increas-
es sharply with age. The risk for TB due to reactivation of
latent infection therefore increases with age as well.
Within the older age groups, this risk is now declining with
each calendar year as earlier birth cohorts leave and more
recent birth cohorts with lower infection prevalence enter
the age group. 
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Figure 1. Tuberculosis incidence (new strains and strains attrib-
uted to recent transmission) among Dutch and non-Dutch in the
Netherlands, 1995–2002.
Figure 2. Incidence rate of tuberculosis (new strains) by age group
among the Dutch, 1995–2002.The incidence of culture-positive TB with new strains
among Dutch persons <65 years of age was stable in the
past decade, at 0.85 per 100,000 population in our matched
dataset, and thus ≈1/100,000 or 10 per million if failure to
match is taken into account. Of these new case-patients
with a known sputum smear result, 63% had smear-posi-
tive TB. If elimination of TB as a public health problem is
defined as achieving an incidence of new smear-positive
TB cases of <1 per million (1), elimination is unlikely to
be achieved under current epidemiologic conditions and
control efforts. 
Our study confirms previous predictions from a mathe-
matical model about the increasing importance of trans-
mission from immigrants to the Dutch population (2). The
number of cases observed among the Dutch is best
explained by immigrant scenarios 1 and 2 in the modeling
study (2), which assume that a Dutch TB patient is 8 times
more likely than a non-Dutch TB patient to infect a Dutch
person. 
Over time, the decline of TB incidence among elderly
Dutch will become less important as the birth cohorts with
a high prevalence of infection are replaced with cohorts
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endemic countries through immigrants and international
travel, on the other hand, is becoming increasingly impor-
tant as a determinant of TB trends in the Netherlands. This
finding was shown in this study by the increasing propor-
tion over time of Dutch patients with secondary cases
attributed to a non-Dutch source patient. This finding sug-
gests the need for further reorientation of the focus of TB
control within the Netherlands towards immigrants and
their contacts and reemphasizes the importance of global
TB control for achieving TB elimination in countries with
low incidence of this disease (14). 
The separation of TB patients into those with new
strains, attributed to reactivation or acquisition abroad, and
secondary cases attributed to recent transmission is likely
to be imperfect for the following reasons. Some strains
identified as new may have represented ongoing transmis-
sion in the presence of strain evolution. Some strains
attributed to ongoing transmission may represent remote
transmission, particularly among the elderly (15). In this
national database, epidemiologic confirmation of linkage
between patients was far from complete (16). However, in
a recent, more detailed study in Amsterdam, most clustered
patients were found to have epidemiologic links (17).
Missing data as a result of incomplete matching may have
contributed to a slight underestimate of the observed clus-
tering percentage and of the number of secondary cases per
source case (18,19). However, since the matching percent-
age was not associated with calender year (data not
shown), this underestimate should not affect the trend esti-
mates. Some source cases may have been misclassified, in
particular in large clusters. These sources of misclassifica-
tion are expected to reduce the observed difference
between cases with new strains and those attributed to
recent transmission but do not invalidate the main conclu-
sion that TB incidence among the Dutch was reduced
mainly because of fewer reactivation cases among persons
>65 years of age. 
We conclude that the decline of TB in the Netherlands
during the past decade was mainly the result of a cohort
effect: older birth cohorts with high infection prevalence
were replaced by those with lower infection prevalence.
Contact through immigrants and international travel with
countries with high TB incidence increasingly determines
TB trends in the Netherlands and will prevent achieving
TB elimination under current conditions. Global TB con-
trol is required to achieve TB elimination in countries with
a low incidence of this disease.
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